Saba Noore, Nasir Jamal Abdul, Waheed Usman, Aslam Sidra, Mohammad Iqbal, Wazeer Akhlaaq, Ahmed Saeed, Nisar Muhammad
Department of Health, Peshawar Regional Blood Centre, Khyber Pakhtunkhwa, Pakistan.
Islamabad Blood Transfusion Authority, Ministry of National Health Services, Government of Pakistan, Pakistan.
J Lab Physicians. 2021 Jun;13(2):162-168. doi: 10.1055/s-0041-1729485. Epub 2021 May 26.
Blood transfusion is linked to several risks, most notably the transmission of transfusion-transmitted infections (TTIs), including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), syphilis, and malaria. The risk posed by these blood-borne infectious agents is high in developing countries, including Pakistan. This fact stresses the need for regular surveillance of TTIs. Therefore, the present study was undertaken to assess the seroprevalence of TTIs at a regional blood center. This was a retrospective 4-year descriptive study undertaken at the Regional Blood Centre in Peshawar, Khyber Pakhtunkhwa Province of Pakistan, on the blood donor data from June 2016 to May 2020. A total of 41,817 donors donated blood during the study period and were screened for HBV, HCV, HIV, syphilis, and malaria. To ensure donor privacy, donors were identified via codes and no personal information was available. The data were extracted from the ZAAVIA blood transfusion information system database. The study included a total of 41,817 donors-41,493 (99.22%) males and 324 (0.78%) females. Of them, 22,343 (53.43%) were voluntary donors while 19,474 (46.57%) were replacement donors. An overall TTI prevalence rate of 4.61% was found. The TTI prevalence rate in voluntary donors was 3.90% while 5.42% in replacement donors. The overall prevalence of HBV, HCV, HIV, syphilis, and malaria was 1.95, 1.38, 0.23, 0.91, and 0.14%, respectively. The current study documented a high prevalence (1,929 out of 41,817, 4.61%) of TTIs, especially in replacement donors (1,057 out of 19,474, 5.42%), and low participation of female donors. The recommendations include the promotion of voluntary blood donors, enrolment of female blood donors, and screening of donated blood through highly sensitive screening assay (i.e., nucleic acid testing).
输血与多种风险相关,最显著的是输血传播感染(TTIs)的传播,包括乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、人类免疫缺陷病毒(HIV)、梅毒和疟疾。在包括巴基斯坦在内的发展中国家,这些血源性病原体带来的风险很高。这一事实凸显了对输血传播感染进行定期监测的必要性。因此,本研究旨在评估某地区血液中心输血传播感染的血清流行率。
这是一项回顾性的4年描述性研究,在巴基斯坦开伯尔-普赫图赫瓦省白沙瓦的地区血液中心进行,研究对象是2016年6月至2020年5月的献血者数据。在研究期间,共有41817名献血者献血,并接受了乙肝、丙肝、艾滋病毒、梅毒和疟疾的筛查。为确保献血者隐私,通过编码识别献血者,不提供个人信息。数据从ZAAVIA输血信息系统数据库中提取。
该研究共纳入41817名献血者,其中男性41493名(99.22%),女性324名(0.78%)。其中,22343名(53.43%)为自愿献血者,19474名(46.57%)为替代献血者。输血传播感染的总体患病率为4.61%。自愿献血者的输血传播感染患病率为3.90%,替代献血者为5.42%。乙肝、丙肝、艾滋病毒、梅毒和疟疾的总体患病率分别为1.95%、1.38%、0.23%、0.91%和0.14%。
本研究记录了输血传播感染的高患病率(41817人中1929人,4.61%),尤其是替代献血者(19474人中1057人,5.42%),以及女性献血者参与率低的情况。建议包括推广自愿献血者、招募女性献血者,以及通过高灵敏度筛查检测(即核酸检测)对捐献血液进行筛查。